Year None20202019201820172016 March 17, 2020 Medicenna Announces Closing of Public Offering of $35 Million Go to March 12, 2020 Medicenna Announces Intention to File Final Short Form Prospectus Go to March 4, 2020 Medicenna Announces Pricing of $35 Million Overnight Marketed Offering of Common Shares Go to March 3, 2020 Medicenna Announces Overnight Marketed Offering of Common Shares Go to February 13, 2020 Medicenna Reports Third Quarter Fiscal 2020 Financial Results Go to January 13, 2020 Medicenna Reports Compelling Results from Recurrent Glioblastoma Trial When Compared to an Eligibility-Matched Control Arm Go to Pagination First page « first Previous page ‹ previous Page 1 Page 2 Current page 3 Page 4 Next page next › Last page last »
March 4, 2020 Medicenna Announces Pricing of $35 Million Overnight Marketed Offering of Common Shares Go to
January 13, 2020 Medicenna Reports Compelling Results from Recurrent Glioblastoma Trial When Compared to an Eligibility-Matched Control Arm Go to
